Nicolini FE, Hayette S, Corm S, Bachy E, Bories D, Tulliez M, Guilhot F, Legros L, Maloisel F, Kiladjian J-J, Mahon F-X, Lê Q-H, Michallet M, Roche-Lestienne C, Preudhomme C. Clinical outcome of 27 imatinib mesylate-resistant chronic myelogenous leukemia patients harboring a T315I BCR-ABL mutation. Haematologica [Internet]. 2007Sep.1 [cited 2026Nov.11];92(9):1238-41. Available from: https://haematologica.org/article/view/4565